[covid-19] Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Posté : 07 juin 2020 12:00
Ma A, et al. Crit Care 2020 - Clinical Trial.
ABSTRACT
ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.
PMID:32503668 | PMC:PMC7273815 | DOI:10.1186/s13054-020-03007-0
Source: https://pubmed.ncbi.nlm.nih.gov/3250366 ... 29&v=2.8.0